Disclosed is an inhibitor of CCR8 that is represented by Structural Formula (I). Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent and a CCR8 inhibitor represented by Structural Formula (I). Also disclosed is a method of treating inflammatory disorders in a subject by administering a CCR8 inhibitor to the subject.
揭示了一种由结构式(I)表示的CCR8
抑制剂。还揭示了包括药用载体或稀释剂和由结构式(I)表示的CCR8
抑制剂的药物组合物。还揭示了通过向受试者施用CCR8
抑制剂来治疗炎症性疾病的方法。